← FDA Drug Approvals (Drugs@FDA)

SYLVANT

BLA · Biologics License Application · Sponsor: RECORDATI RARE DISEASES, INC. · Approved 2014-04-23

Drug application

FDA Application #
BLA125496
Application type
Biologics License Application
Brand name
SYLVANT
Generic name
SILTUXIMAB
Active ingredients
SILTUXIMAB
Dosage form
INJECTABLE
Route
INJECTION
Marketing status
Prescription
Sponsor
RECORDATI RARE DISEASES, INC.
Manufacturer
Recordati Rare Diseases, Inc.
First approval
2014-04-23

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown